BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12642576)

  • 1. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
    Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
    J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
    Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
    J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
    Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
    J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue].
    Saulnier-Blache JS
    J Soc Biol; 2006; 200(1):77-81. PubMed ID: 17144165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
    van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
    J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production.
    Simon MF; Rey A; Castan-Laurel I; Grés S; Sibrac D; Valet P; Saulnier-Blache JS
    J Biol Chem; 2002 Jun; 277(26):23131-6. PubMed ID: 11956205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
    Boucher J; Quilliot D; Pradères JP; Simon MF; Grès S; Guigné C; Prévot D; Ferry G; Boutin JA; Carpéné C; Valet P; Saulnier-Blache JS
    Diabetologia; 2005 Mar; 48(3):569-77. PubMed ID: 15700135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases.
    Murata J; Lee HY; Clair T; Krutzsch HC; Arestad AA; Sobel ME; Liotta LA; Stracke ML
    J Biol Chem; 1994 Dec; 269(48):30479-84. PubMed ID: 7982964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
    Tokumura A; Majima E; Kariya Y; Tominaga K; Kogure K; Yasuda K; Fukuzawa K
    J Biol Chem; 2002 Oct; 277(42):39436-42. PubMed ID: 12176993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase.
    Pradère JP; Tarnus E; Grès S; Valet P; Saulnier-Blache JS
    Biochim Biophys Acta; 2007 Jan; 1771(1):93-102. PubMed ID: 17208043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.
    Valet P; Pagès C; Jeanneton O; Daviaud D; Barbe P; Record M; Saulnier-Blache JS; Lafontan M
    J Clin Invest; 1998 Apr; 101(7):1431-8. PubMed ID: 9525986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.
    Gijsbers R; Aoki J; Arai H; Bollen M
    FEBS Lett; 2003 Mar; 538(1-3):60-4. PubMed ID: 12633853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
    Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
    Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, regulation and function of autotaxin in thyroid carcinomas.
    Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
    Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.
    Dusaulcy R; Rancoule C; Grès S; Wanecq E; Colom A; Guigné C; van Meeteren LA; Moolenaar WH; Valet P; Saulnier-Blache JS
    J Lipid Res; 2011 Jun; 52(6):1247-1255. PubMed ID: 21421848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
    J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis.
    Gesta S; Simon MF; Rey A; Sibrac D; Girard A; Lafontan M; Valet P; Saulnier-Blache JS
    J Lipid Res; 2002 Jun; 43(6):904-10. PubMed ID: 12032165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
    David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
    PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid.
    Tanaka M; Okudaira S; Kishi Y; Ohkawa R; Iseki S; Ota M; Noji S; Yatomi Y; Aoki J; Arai H
    J Biol Chem; 2006 Sep; 281(35):25822-30. PubMed ID: 16829511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.